Search results
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 3 days agoNet income: UK£1.05b (down 30% from 1Q 2023). Profit margin: 14% (down from 21% in 1Q 2023). EPS:...
Barinthus Bio names Leon Hooftman as new CMO By Investing.com
Investing.com· 3 days agoBarinthus Biotherapeutics plc (NASDAQ: BRNS), a biopharmaceutical company focused on T cell...
Earnings will drive the market next week — what we expect from 2 portfolio stocks
CNBC· 10 hours agoWithout any major economic reports, earnings — especially forward guidance and management commentary...
Drugmakers Exposed to Antitrust Probes if Patent Cache Adopted
Bloomberg Law· 4 days agoA proposed patent office depository for sealed settlements could expose pharmaceutical giants to antitrust scrutiny if investigators use it to identify which companies may ...
Cell and gene therapy companies trip at scalability hurdle
Pharmaceutical Technology via Yahoo Finance· 6 days ago...for Regenerative Medicine, says that regulatory support for the industry would be a major boon...
Earnings call: Cencora Q2 2024 results show strong financial performance By Investing.com
Investing.com· 3 days agoCencora (NYSE:COR) reported an 8% increase in revenue and a 9% rise in adjusted EPS during its Q2...
Terns reports progress in TERN-701 CML drug trial By Investing.com
Investing.com· 5 days agoTerns Pharmaceuticals, Inc. (NASDAQ:TERN), a biopharmaceutical company focusing on the development...
Judge rejects J&J, BMS challenges to Medicare drug pricing program
NJBIZ· 3 days agoA federal judge in New Jersey tossed lawsuits from Johnson & Johnson and Bristol Myers Squibb...
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
Zacks· 3 days agoGAAP EPS in the quarter was $1.05 compared with $1.34 in the year-ago period. In the reported...
ARS Pharma submits response to EMA for neffy approval By Investing.com
Investing.com· 4 days agoARS Pharmaceuticals, Inc. (NASDAQ: SPRY) has submitted its response to the European Medicines...